开发,特征和辐射剂量测量研究F-BMS-986229,一个F-标记PD-L1宏环PET标记仪
Joonyoung Kim1, David J Donnelly2, Tritin Tran2
1Bristol Myers Squibb Research and Early Development, P.O. Box 4000, Princeton, NJ, 08543, USA. joonyoung.kim@bms.com.
Molecular imaging and biology
|December 20, 2023
概括
一种新的F-标记的标记器,F-BMS-986229,可以准确,定量评估被编程的死亡配体1 (PD-L1) 表达. 这种PET追踪器对监测癌症患者免疫疗法反应有前途.
科学领域:
- 核医学就是核医学.
- 在瘤学瘤学.
- 放射化学 放射化学是指辐射化学.
背景情况:
- 针对编程死亡-1 (PD-1) 和编程死亡-连接体1 (PD-L1) 相互作用的癌症免疫疗法是一个有希望的策略.
- 对PD-1/PD-L1抑制的耐药性可能来自可变的瘤细胞PD-L1表达,需要超越标准免疫组织化学 (IHC) 的高级定量评估.
- 需要一种全面和定量方法来测量PD-L1表达,以改善治疗策略.
研究的目的:
- 开发和描述一种新的F标记的宏环标记器,用于正子发射断层扫描 (PET) 成像.
- 评估追踪器在癌症患者中全面评估瘤PD-L1表达的能力.
- 调查追踪器在监测纵向变化和预测免疫治疗结果方面的潜力.
主要方法:
- 使用体外和体外自发放射学进行F-BMS-986229的表征.
- 在小鼠体内进行PET成像,以评估标记物吸收和与PD-L1抑制剂的向接触 (BMS-986189).
- 在健康的非人类灵长类动物 (NHPs) 中对F-BMS-986229进行全身辐射剂量测试.
主要成果:
- 在体外自射成像显示了对PD-L1表达瘤的高结合特异性 (8:1比).
- 在小鼠体内PET成像显示,PD-L1阳性瘤具有高特异性结合 (>83%) 的显著标志物吸收.
- 在NHP的剂量测试研究表明,低全身有效剂量 (0.025 mSv/MBq),支持临床适用性.
结论:
- F-BMS-986229已在临床前验证为具有高目标特异性和低背景吸收的PET追踪剂.
- 追踪器的短血半衰期允许在同一天进行成像,从而促进临床使用.
- 在癌症免疫治疗中,F-BMS-986229显示了量化PD-L1表达和监测治疗反应的显著潜力.
相关概念视频
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
![Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate [18F]SFB](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F2755.jpg&w=3840&q=50)
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
